2016 update of the EULAR recommendations for the management of rheumatoid arthritis: a utopia beyond patients in low/middle income countries?

Ann Rheum Dis. 2017 Nov;76(11):e47. doi: 10.1136/annrheumdis-2017-211446. Epub 2017 Mar 27.
No abstract available

Keywords: DMARDs (biologic); DMARDs (synthetic); Rheumatoid Arthritis.

Publication types

  • Letter
  • Comment

MeSH terms

  • Antirheumatic Agents*
  • Arthritis, Rheumatoid*
  • Biological Products*
  • Developing Countries
  • Humans
  • Utopias

Substances

  • Antirheumatic Agents
  • Biological Products